In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Drug Pricing Reforms Testing Limits Of Executive Action

Executive Summary

Congressional inaction on drug pricing legislation has meant the Trump Administration is pursuing a menu of regulatory approaches. For the most part, that means slower and incremental change.

 

Advertisement

Related Content

No, It's Not Just Out-Of-Pocket Costs That Are A Problem, John Arnold Tells Pharma
On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019
Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues
Amgen Drops Repatha List Price 60% To Cut Medicare Co-Pays And Boost Use
Drug Pricing Reform In Medicare And Medicaid: Upcoming Regulatory Actions
DTC Advertising: The 'Kick Me' Sign On Big Pharma’s Backs
DTC Ad Price Disclosure Provision Stripped From US Funding Bill
Oklahoma Medicaid Plan For Value-Based Contracts Cleared By CMS
'Immediate' Steps To Lower Drug Prices: The HHS Action Plan

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV123588

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel